Early and Personalized Rituximab Treatment Preserves Kidney Function in Membranous Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-OR071; Pres time: Oct 22, 2026; 05:40 PM - 05:50 PM; Location: Room 501, Convention Center; "Clinical remission rates, the intensity of symptomatic treatment, and the cumulative anti-CD20 dose used for retreatment were comparable between the two groups. Conclusion Early and intensive rituximab treatment improves long-term renal outcomes, whereas delayed treatment, particularly in immunologically aggressive MN, is associated with greater renal function decline."
Glomerulonephritis • Immunology • Nephrology • Renal Disease
|
|
Maxime Teisseyre; Kévin Zorzi; Vesna Brglez; Barbara Seitz-Polski
|